Mark Yates Selected Research

remdesivir

1/2022

Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Yates Research Topics

Disease

7	COVID-19 12/2023 - 01/2020
4	Infections 10/2021 - 10/2016
3	Neoplasms (Cancer) 01/2023 - 01/2020
3	Rheumatoid Arthritis 01/2021 - 10/2019
3	Dementia (Dementias) 09/2019 - 02/2017
2	Cognitive Dysfunction 01/2023 - 09/2019
2	Hypertension (High Blood Pressure) 01/2022 - 01/2020
2	Arthritis (Polyarthritis) 01/2022 - 01/2019
2	Rheumatic Diseases (Rheumatism) 10/2019 - 01/2019
1	Stroke (Strokes) 07/2022
1	Melanoma (Melanoma, Malignant) 07/2022
1	Necrosis 07/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2022
1	Skin Neoplasms (Skin Cancer) 07/2022
1	Fatigue 01/2022
1	Pain (Aches) 01/2022
1	Obesity 01/2022
1	Pulmonary Embolism 01/2021
1	Herpes Zoster 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Venous Thromboembolism 01/2021
1	Gout 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Diabetes Mellitus 01/2020
1	Disease Susceptibility (Diathesis) 10/2016
1	Autoimmune Diseases (Autoimmune Disease) 10/2016

Drug/Important Bio-Agent (IBA)

3	Janus Kinase InhibitorsIBA 07/2022 - 01/2021
3	Tumor Necrosis Factor InhibitorsIBA 10/2021 - 01/2020
2	GlucocorticoidsIBA 01/2023 - 07/2022
2	Interleukin-6 InhibitorsIBA 07/2022 - 01/2021
2	Immunomodulating AgentsIBA 10/2021 - 01/2021
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2020
2	O,O'- dimethyl- O- (6- chlorobicyclo(3.2.0)heptadiene- 1,5- yl)phosphateIBA 09/2019 - 01/2018
1	COVID-19 VaccinesIBA 12/2023
1	ORALIT (ORS)IBA 01/2023
1	Antirheumatic Agents (DMARD)IBA 01/2023
1	Rituximab (Mabthera)FDA Link 07/2022
1	Interleukin-12 (IL 12)IBA 07/2022
1	InterleukinsIBA 07/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	remdesivirIBA 01/2022
1	Prostaglandins AIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021
1	upadacitinibIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	GLPG0634IBA 01/2021
1	EnzymesIBA 01/2021
1	LipidsIBA 01/2021
1	sarilumabIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	AlbuminsIBA 01/2020
1	CreatinineIBA 01/2020
1	CytokinesIBA 01/2019
1	tofacitinibIBA 01/2019
1	Janus KinasesIBA 01/2019
1	baricitinibIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 10/2016
1	IntegrinsIBA 10/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2016

Therapy/Procedure

5	Therapeutics 07/2022 - 01/2020
1	Length of Stay 01/2023
1	Self Care (Care, Self) 01/2022
1	Critical Care (Surgical Intensive Care) 01/2020
1	Polypharmacy 10/2019
1	Occupational Therapy (Therapy, Occupational) 02/2017